Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis.

PubWeight™: 2.24‹?› | Rank: Top 2%

🔗 View Article (PMC 1538403)

Published in Clin Exp Immunol on May 01, 1976

Authors

K Lidman, G Biberfeld, A Fagraeus, R Norberg, R Torstensson, G Utter, L Carlsson, J Luca, U Lindberg

Articles citing this

Antibodies to tubulin in normal nonimmunized animals. Proc Natl Acad Sci U S A (1977) 1.91

Antibody to intermediate filaments of the cytoskeleton. Ann Rheum Dis (1982) 1.45

Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol (1979) 1.42

Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34

Antitubulin antibody in healthy adults and patients with infectious mononucleosis and its relationship to smooth muscle antibody (SMA). Clin Exp Immunol (1980) 1.30

Experimental smooth muscle antibodies. Clin Exp Immunol (1977) 1.21

Smooth muscle antibodies in Mycoplasma pneumoniae infection. Clin Exp Immunol (1976) 1.17

Immunoglobulin M autoantibody to vimentin intermediate filaments. J Clin Invest (1982) 1.16

Oligoclonal immunoglobulins and smooth muscle antibodies in arthritic joints. Clin Exp Immunol (1980) 1.06

Localization of amyloid-related serum protein SAA-like material to intermediate (10 nm) filaments of cultured human embryonal fibroblasts. J Exp Med (1977) 1.05

Autoantibody-negative autoimmune hepatitis. Dig Dis Sci (2011) 1.03

Antigenic mimicry of mammalian intermediate filaments by mycoplasmas. Infect Immun (1985) 1.02

Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci (2010) 1.01

Three monoclonal antibodies against measles virus F protein cross-react with cellular stress proteins. J Virol (1984) 1.00

Fixation of human anti-actin autoantibodies on skeletal muscle fibres. Clin Exp Immunol (1977) 0.98

Correlation of smooth-muscle and nuclear antibodies in normal subjects. Clin Exp Immunol (1977) 0.93

Circulating actin-gelsolin complexes following oleic acid-induced lung injury. Am J Pathol (1988) 0.92

Myosin autoantibodies detected by immunofluorescence. Clin Exp Immunol (1977) 0.92

Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura. J Clin Pathol (1979) 0.92

Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol (1987) 0.90

A membrane-associated autoantibody in a case of myasthenia gravis with chronic hepatitis. Clin Exp Immunol (1976) 0.89

Reaction of human smooth muscle autoantibody with gastric parietal cells: a pitfall in the diagnosis of parietal cell autoantibody. J Clin Pathol (1977) 0.87

Reactivity of smooth-muscle antibodies with F- and G-actin. Immunology (1979) 0.85

Anti-actin antibodies revealed by counter-immunoelectrophoresis. Relation to smooth muscle antibodies and bile canalicular antibodies. J Clin Pathol (1980) 0.85

Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases. Clin Exp Immunol (1983) 0.84

A 50-year experience with autoimmune hepatitis: and where are we now? J Gastroenterol (2010) 0.83

Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma. Clin Exp Immunol (1977) 0.82

Multiple myeloma and monoclonal IgA with anti-actin reactivity. Clin Exp Immunol (1977) 0.82

Increased expression of actin-like contractile protein in preneoplastic and neoplastic lesions in rat liver. Br J Cancer (1977) 0.81

Haemagglutinating anti-actin antibodies in acute and chronic liver disease. Gut (1980) 0.81

Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance. Gut (1980) 0.81

The reaction of cells with anti-actin sera in relation to the amount of cellular actin. Clin Exp Immunol (1977) 0.80

Reaction against liver cells by human antiactin antibodies purified by affinity chromatography. J Clin Pathol (1982) 0.80

Antibodies to skeletal muscle actin and their reactivity with malignant melanoma of the choroid. Br J Ophthalmol (1980) 0.80

Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights (2013) 0.78

Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis. PLoS One (2014) 0.78

Characterisation of Liver membrane autoantibodies determined by indirect immunofluorescence. J Clin Pathol (1982) 0.78

Lack of cross-reactivity between antibody against smooth muscle and antibodies to measles virus in sera from patients with chronic active hepatitis. J Clin Pathol (1982) 0.75

Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus. J Clin Invest (1992) 0.75

Anti-spectrin in sera containing smooth muscle autoantibodies from patients with chronic active hepatitis. Clin Exp Immunol (1981) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J Mol Biol (1973) 30.17

Actin and myosin and cell movement. CRC Crit Rev Biochem (1974) 15.33

Actin antibody: the specific visualization of actin filaments in non-muscle cells. Proc Natl Acad Sci U S A (1974) 11.64

Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli. Biochemistry (1968) 6.68

Antibody to smooth muscle in patients with liver disease. Lancet (1965) 5.71

Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J (1970) 4.08

Reaction of human smooth muscle antibody with liver cells. Nat New Biol (1971) 4.06

Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet (1966) 3.45

Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol (1973) 3.36

Complete amino-acid sequence of actin of rabbit skeletal muscle. Proc Natl Acad Sci U S A (1973) 2.96

Smooth muscle autoantibodies in infectious mononucleosis. Br Med J (1973) 2.44

The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol (1974) 2.00

Immunofluorescent tracing of smooth muscle contractile protein antigens in tissues other than smooth muscle. Clin Exp Immunol (1974) 1.93

Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature (1974) 1.54

Structural proteins of adenoviruses. XI. Purification of three low molecular weight virion proteins of adenovirus type 2 and their synthesis during productive infection. Virology (1974) 1.54

Australia antigen in hepatitis among Swedish track-finders. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.25

Ultrastructural localization of actin-like filaments in rat hepatocytes. Gastroenterology (1975) 1.24

Improved technique for detecting Australia antigen by immunoelectroosmophoresis. Vox Sang (1971) 1.24

Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol (1974) 1.24

Reaction of human smooth muscle antibody with thymus medullary cells. Nat New Biol (1973) 1.22

Smooth muscle antibodies in Mycoplasma pneumoniae infection. Clin Exp Immunol (1976) 1.17

Smooth muscle antibody in patients with warts. Clin Exp Immunol (1975) 1.14

Studies on thrombosthenin a, the actin-like moiety of the contractile protein from blood platelets. I. Isolation, characterization and evidence for two forms of thrombosthenin A. Biochim Biophys Acta (1972) 1.12

Reactivity of smooth-muscle antibodies, surface ultrastructure, and mobility in cells of human hematopoietic cell lines. J Natl Cancer Inst (1975) 0.92

Articles by these authors

Insulin-promoter-factor 1 is required for pancreas development in mice. Nature (1994) 10.13

Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet (1976) 7.15

Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res (2003) 5.39

Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24

Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin. Nature (1985) 4.60

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52

Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc Natl Acad Sci U S A (1974) 4.35

Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells. J Mol Biol (1977) 4.31

The structure of crystalline profilin-beta-actin. Nature (1993) 4.22

Ultrastructural features of Mycoplasma pneumoniae. J Bacteriol (1970) 3.84

Isolation and characterization of adenovirus messenger ribonucleic acid in productive infection. J Virol (1972) 3.83

Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I. Cell (1978) 3.74

Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol (1996) 3.13

SV40-specific RNA in the nucleus and polyribosomes of transformed cells. Proc Natl Acad Sci U S A (1970) 3.05

Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg Br (1995) 3.00

RNA synthesis and processing in adenovirus-infected cells. Cold Spring Harb Symp Quant Biol (1975) 2.82

HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr (2001) 2.81

Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol (1971) 2.76

Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J Infect Dis (1977) 2.72

Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS (1997) 2.60

Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection. J Pediatr (1978) 2.60

Isolation of mRNA from KB-cells by affinity chromatography on polyuridylic acid covalently linked to Sepharose. Eur J Biochem (1972) 2.48

The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections. Infection (1973) 2.39

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet (1986) 2.38

Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand (1975) 2.32

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28

Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol (1999) 2.23

The structure of an open state of beta-actin at 2.65 A resolution. J Mol Biol (1996) 2.23

Characterization of messenger ribonucleoprotein and messenger RNA from KB cells. Proc Natl Acad Sci U S A (1972) 2.20

Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation (2001) 2.11

Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08

Reorganization of actin in platelets stimulated by thrombin as measured by the DNase I inhibition assay. Proc Natl Acad Sci U S A (1979) 2.02

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99

Depolymerization of F-actin by deoxyribonuclease I. Cell (1976) 1.96

Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol (1997) 1.94

New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89

HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol (1986) 1.88

Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature (1976) 1.83

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia (2011) 1.79

Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand (1975) 1.76

A method for the determination of dATP and dTTP in picomole amounts. Anal Biochem (1970) 1.76

Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults. J Clin Microbiol (1997) 1.76

Isolation of messenger ribonucleoproteins from mammalian cells. J Mol Biol (1974) 1.72

F-Actin-depolymerizing activity of human serum. Eur J Biochem (1979) 1.71

Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr (2000) 1.70

Mixed haemadsorption: a mixed antiglobulin reaction applied to antigens on a glass surface. Preparation and evaluation of indicator red cells; survey of present applications. Immunology (1965) 1.68

Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology (1997) 1.67

A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67

Further immunological studies of sera containing anti-mitochondrial antibodies, type M 5. Clin Exp Immunol (1984) 1.63

Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61

Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol (1987) 1.61

Evidence for circulating immune complexes in sarcoidosis. Clin Exp Immunol (1974) 1.59

Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59

Specificity of the interaction between phosphatidylinositol 4,5-bisphosphate and the profilin:actin complex. J Cell Biochem (1988) 1.57

The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Biol Chem (1992) 1.55

Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature (1974) 1.54

Visualization of the peripheral weave of microfilaments in glia cells. J Muscle Res Cell Motil (1980) 1.53

Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet (1986) 1.53

The mixed haemadsorption test as an aid to the diagnosis of thyroid autoimmune disease. Clin Exp Immunol (1968) 1.52

Most HIV-1 genetic subtypes have entered Sweden. AIDS (1997) 1.52

Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc Natl Acad Sci U S A (1989) 1.48

Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections. J Infect Dis (1977) 1.48

Domain motions in actin. J Mol Biol (1998) 1.47

Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau. J Clin Microbiol (1993) 1.47

The primary structure of human platelet profilin: reinvestigation of the calf spleen profilin sequence. FEBS Lett (1988) 1.47

Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3-year follow-up. J Pediatr (1978) 1.45

Characterization of platelet extracts before and after stimulation with respect to the possible role of profilactin as microfilament precursor. Cell (1981) 1.45

Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods. J Immunol Methods (2003) 1.45

Plugging into actin's architectonic socket. Nat Struct Biol (1997) 1.45

Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol (1997) 1.44

Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme. BMJ (1993) 1.43

Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis (1969) 1.41

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41

Crystallization of a non-muscle actin. J Mol Biol (1976) 1.40

Analysis of the V3 loop in neutralization-resistant human immunodeficiency virus type 1 variants by direct solid-phase DNA sequencing. AIDS Res Hum Retroviruses (1991) 1.39

[Reasons for HIV testing. Casual sexual contacts are the most common reasons for voluntary HIV testing]. Lakartidningen (1994) 1.39

The amino acid sequence of profilin from calf spleen. FEBS Lett (1979) 1.39

Human platelets contain profilin, a potential regulator of actin polymerisability. FEBS Lett (1978) 1.39

Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Methods (1998) 1.39

Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J Virol (2000) 1.38

T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun (1983) 1.37

Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med (2000) 1.37

Tuberculosis mortality during a civil war in Guinea-Bissau. JAMA (2001) 1.36

Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res (1985) 1.36

Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res Hum Retroviruses (1996) 1.36

Multilocus markers for mouse genome analysis: PCR amplification based on single primers of arbitrary nucleotide sequence. Mamm Genome (1992) 1.36

Expression of the LIM-homeobox gene LH2 generates immortalized steel factor-dependent multipotent hematopoietic precursors. EMBO J (1998) 1.35